Literature DB >> 18367001

Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.

Geesje M Dallinga-Thie1, Robin P F Dullaart, Arie van Tol.   

Abstract

In type 2 diabetes mellitus, elevated fasting and postprandial plasma triglycerides, small dense low-density lipoprotein particles, low high-density lipoprotein (HDL) cholesterol levels, and increased action of lipid transfer proteins may enhance peripheral lipid accumulation and increase cardiovascular risk. Despite low HDL cholesterol, plasma's ability to stimulate cellular cholesterol efflux, reflecting an early step in the reverse cholesterol transport pathway, appears to be maintained, perhaps implicating a compensatory mechanism.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18367001     DOI： 10.1007/s11892-008-0012-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  62 in total

1.  Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease.

Authors:  Gerald Reaven
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

2.  Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.

Authors:  R de Vries; A K Groen; F G Perton; G M Dallinga-Thie; M J A van Wijland; L D Dikkeschei; B H R Wolffenbuttel; A van Tol; R P F Dullaart
Journal:  Atherosclerosis       Date:  2007-02-01       Impact factor: 5.162

3.  Proteomic analysis of high-density lipoprotein.

Authors:  Farhad Rezaee; Bruno Casetta; J Han M Levels; Dave Speijer; Joost C M Meijers
Journal:  Proteomics       Date:  2006-01       Impact factor: 3.984

4.  Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.

Authors:  M Guérin; W Le Goff ; T S Lassel; A Van Tol ; G Steiner; M J Chapman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

Review 5.  Managing diabetic dyslipidaemia--beyond LDL-C:HDL-C and triglycerides.

Authors:  Philip Barter
Journal:  Atheroscler Suppl       Date:  2006-07-07       Impact factor: 3.235

Review 6.  An overview of reverse cholesterol transport.

Authors:  A R Tall
Journal:  Eur Heart J       Date:  1998-02       Impact factor: 29.983

7.  Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux.

Authors:  Nan Wang; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-08       Impact factor: 8.311

8.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

9.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired.

Authors:  Ming-Dong Wang; Vivian Franklin; Yves L Marcel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-31       Impact factor: 8.311
View more
  3 in total

1.  HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study.

Authors:  Sara Sokooti; Jose L Flores-Guerrero; Lyanne M Kieneker; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

2.  High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients.

Authors:  Sara Sokooti; Tamas Szili-Torok; Jose L Flores-Guerrero; Maryse C J Osté; António W Gomes-Neto; Jenny E Kootstra-Ros; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  Biomolecules       Date:  2020-03-21

3.  Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes.

Authors:  Hanna Wessel; Ali Saeed; Janette Heegsma; Margery A Connelly; Klaas Nico Faber; Robin P F Dullaart
Journal:  J Clin Med       Date:  2019-10-25       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.